CN Stock MarketDetailed Quotes

688266 Suzhou Zelgen Biopharmaceuticals

Watchlist
  • 61.51
  • -1.60-2.54%
Trading Jan 16 14:37 CST
16.28BMarket Cap-93.34P/E (TTM)

Suzhou Zelgen Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Suzhou Zelgen Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.221B--
--2024/FY-- / 600.000M--
--2023/FY386.439M / 429.000M--
--2021/FY201.107M / 208.000M--
--2020/FY27.661M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.221B--
--2024/FY-- / 600.000M--
--2023/FY386.439M / 429.000M--
--2021/FY201.107M / 208.000M--
--2020/FY27.661M / 0.000--

Unlock Free Earnings Estimates

Suzhou Zelgen Biopharmaceuticals Earnings Reports

  • Zejing Pharmaceutical Report for the Third Quarter of 2024

    Oct 25, 2024 12:00 ET

  • ZeJing Pharmaceutical's 2024 interim report

    Aug 23, 2024 12:00 ET

  • Summary of Zejing Pharmaceuticals' semi-annual report for 2024

    Aug 23, 2024 12:00 ET

  • Zejing Pharmaceutical 2023 Annual Report

    Apr 19, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    SMTC
    872374
    35.49 +20.92%
    Marssenger Kitchenware
    300894
    15.23 +20.02%
    Hangzhou Onechance Tech Corp.
    300792
    37.60 +20.01%
    Hangzhou Hopechart Iot Technology Co., Ltd
    688288
    21.24 +20.00%
    Beijing Waluer Information Technology
    301380
    54.07 +20.00%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Jan 16, 2025

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      20.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data